SDMA Quartiles | |||||
---|---|---|---|---|---|
 | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | p Value |
No. of patients | 29 | 29 | 28 | 33 | Â |
SDMA, μM/L | < 0.44 | 0.45–0.51 | 0.52–0.57 | ≥ 0.58 |  |
Demographics | |||||
 Age, yr | 52.8 ± 12.4 | 59.7 ± 15.4 | 62.5 ± 10.9 | 66.7 ± 11.2 | < 0.001a |
 BMI, kg/m2 | 29.24 ± 6.83 | 27.55 ± 4.79 | 28.55 ± 8.2 | 29.67 ± 5.38 | 0.592 |
Disease activity | |||||
 Disease duration, yr | 11.19 ± 9.91 | 13 ± 10.14 | 10.48 ± 7.05 | 11.96 ± 11.02 | 0.805 |
 DAS28 | 3.47 (2.51–3.9) | 2.06 (1.38–2.87) | 2.42 (1.71–2.91) | 2.76 (1.82–3.63) | 0.117 |
CV burden and assessments, n (%) | Â | Â | |||
 History of diabetes, | 5 (17.24%) | 7 (24.14%) | 3 (10.71%) | 6 (18.18%) | 0.621 |
  History of hyperlipidemia | 9 (31%) | 17 (58.6%) | 9 (32.1%) | 21 (63.6%) | 0.014a |
  History of hypertension | 13 (44.8%) | 17 (58.6%) | 15 (53.6%) | 26 (78.8%) | 0.039a |
 Two or more CV risk factors | 8 (27.6%) | 14 (48.3%) | 6 (21.4%) | 18 (54.5%) | 0.022a |
 History of CVD | 4 (13.8%) | 2 (6.9%) | 5 (17.9%) | 6 (18.2%) | 0.585 |
 Smoking | 14 (48.3%) | 12 (41.4%) | 11 (39.3%) | 20 (60.6%) | 0.330 |
Laboratory examination results | |||||
 ESR, mm/h | 14.5 (8.25–28.75) | 11 (7–30) | 10 (7–24) | 21 (9–28.75) | 0.944 |
 CRP, mg/dl | 0.6 (0.2–1.7) | 0.3 (0.2–0.6) | 0.4 (0.1–1) | 0.6 (0.2–1.6) | 0.678 |